Eur. Fdn. for the Study of Chronic Liver Failure

@ef_clif

Here to advance knowledge and improve clinical practice in the diagnosis and treatment of cirrhosis and its complications for better health and quality of life.

Barcelona, Europe

Joined June 2018

127Following

866Followers

Pinned

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · May 14

Get an inside look at the progress, partnerships, and breakthroughs shaping the future of #chronicliverdisease research in our annual report 2024. Dive in! view.genially.com/67f614412f5bd2…

139

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Thomas Reiberger@ReibergerThomas · Jul 28

@ef_clif Advanced Training Course on Research in #Hepatology #LiverDisease #ACLF

158

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · Jul 9

Ready to take your next career step in liver disease research? Prof. @JonelTrebicka introduces #ClinicalResearch in #Hepatology, a specialization in our new Master program. Want to learn more? Fill out the form forms.office.com/e/M2p4YGNjFv and we’ll provide you with more details.

580

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · Jul 2

Patient recruitment update: Enrollment ongoing for #CHANCE phase 2 to define futility criteria for #livertransplant in severe #ACLF. Of 98 patients recruited from 17 hospitals across Europe, Latin America, and North America, 56 have been transplanted and 42 are on waiting list.

ef_clif's tweet image. Patient recruitment update: Enrollment ongoing for #CHANCE phase 2 to define futility criteria for #livertransplant in severe #ACLF. Of 98 patients recruited from 17 hospitals across Europe, Latin America, and North America, 56 have been transplanted and 42 are on waiting list.

153

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Juan Manuel Diaz MD, MSc, PhD(c)@juanmadiazach · Jul 1

The leadership and coordination teams are currently working on the first core publication from the CHANCE study, which will focus on key clinical endpoints and early findings efclif.com/news/chance-st…

140

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Decision4Liver@Decision4Liver · Jun 30

🔥 We’ve hit 50% recruitment in the #COMBATtrial! Huge thanks to all involved!💙 @RautouE @ef_clif @hospitalclinic @LiverIcu @UniklinikAachen @Unibo @Zac_MD @DrAAlbillos @unito @VHIR_ @APHP @UK_Muenster @MEDB_LAB @UschnerFrank @rajmookerjee #LiverTwitter #ACLF #ClinicalTrials

336

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Decision4Liver@Decision4Liver · Jun 26

🎥 New keynote online! Prof. Richard Moreau, Director of @ef_clif, explores immune dysfunction in AD & #ACLF and suggests a common mechanism behind inflammation & immune deficiency. Watch now 👉 youtu.be/KWoUbTsNjQM #LiverTwitter #Hepatology

249

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · Jun 26

Thinking about advancing your career in hepatology research? Get a closer look at our Master Program — from course structure to expert instructors. Pre-registration opens in July! Request more info today: forms.office.com/e/M2p4YGNjFv

360

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · Jun 18

Our Master program bridges clinical insight and research excellence. Hear Richard Moreau introduce Foundations and Management of #ChronicLiverDisease—a must for future hepatology researchers. Pre-registration opens in July! What would you hope to learn?

345

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · Jun 11

Our Master program bridges the gap between cutting-edge #hepatologyresearch and real-world #clinicalcare. Hear from Paolo Angeli about everything it covers. Enrollment opens in July! Tell us: What do you hope to gain from this program?

207

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Ezequiel Mauro@ezemauro_ok · May 10

5/ Two fantastic studies from Argentina: 🫀NT-proBNP predicts ACLF & mortality in LT candidates 🇦🇷 🦠 Torque Teno Virus as biomarker of immune status in liver transplant recipients 🇦🇷 @MMendizabalMD @juanmadiazach @ef_clif

355

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Juan Manuel Diaz MD, MSc, PhD(c)@juanmadiazach · May 11

Reflections after another inspiring #EASL2025 Congress in Amsterdam @EASLnews @EASLedu @ef_clif @genfit_pharma @idibaps @hospitalclinic @LTxJournal linkedin.com/posts/juan-man…

271

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · May 9

Don't miss Thierry Gustot, Principal Investigator of the #CHANCE study and Vice-Chair of the @EASLnews-CLIF Consortium Steering Committee at #EASLCongress 2025 on one-week criteria of potential care inappropriateness for patients w/#ACLF not eligible for #livertransplantation

DDecision4Liver@Decision4Liver · May 9

🔬 #POSTER FRI-222 by Thierry Gustot (EF CLIF) proposes one-week criteria to assess the appropriateness of continuing intensive care in ACLF patients who are not candidates for liver transplantation. #EASL2025 @EASLnews @ef_clif

268

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Decision4Liver@Decision4Liver · May 9

Greetings from the DECISION Investigator Meeting at #EASL2025: Study updates and collaborative discussions with Paolo Caraceni & Pierre-Emmanuel Rautou @EASLnews @ef_clif

171

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Decision4Liver@Decision4Liver · May 9

Kicking off our #EASL2025 Networking Session with an intro to the DECISION project by Pierre-Emmanuel Rautou - Let’s talk systems medicine, cirrhosis, and precision care! @RautouE @ef_clif @EASLnews #LiverDisease

704

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

Decision4Liver@Decision4Liver · May 9

Lastly at DECISION's Networking Session, Richard Moreau shares new data: high-throughput omics reveals biomarkers for infection & poor outcomes in cirrhosis. @ef_clif @Inserm @EASLnews #Metabolomics #Cytokinomics #EASL2025

326

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · May 8

This p.m. at the @EASLnews-CLIF-C General Assembly, our General Manager shared highlights of 2024, followed by presentations on the #ACLF diagnosis harmonization survey, the CLIF-@BavenoCoop joint project on natural history of compensated #cirrhosis, and our new training program.

ef_clif's tweet image. This p.m. at the @EASLnews-CLIF-C General Assembly, our General Manager shared highlights of 2024, followed by presentations on the #ACLF diagnosis harmonization survey, the CLIF-@BavenoCoop joint project on natural history of compensated #cirrhosis, and our new training program.

411

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · May 8

To everyone involved in the #CHANCE study: Join us today for our 8th CHANCE Investigator Meeting @ #EASLCongress 2025 Non-industry Meeting Room 1 (Level 2). We'll share results, the publications plan, and how to submit ancillary studies. Looking forward to seeing you all there!

ef_clif's tweet image. To everyone involved in the #CHANCE study: Join us today for our 8th CHANCE Investigator Meeting @ #EASLCongress 2025 Non-industry Meeting Room 1 (Level 2). We'll share results, the publications plan, and how to submit ancillary studies. Looking forward to seeing you all there!

159

Eur. Fdn. for the Study of Chronic Liver Failure@ef_clif · May 7

Thank you to everyone who stopped by our Track Hub today at #EASLCongress 2025! We're grateful for your time, curiosity, and thoughtful questions. Let’s keep the conversation going and shape the future of #chronicliverdisease research together.

ef_clif's tweet image. Thank you to everyone who stopped by our Track Hub today at #EASLCongress 2025! We're grateful for your time, curiosity, and thoughtful questions. Let’s keep the conversation going and shape the future of #chronicliverdisease research together.

418

Eur. Fdn. for the Study of Chronic Liver Failure Retweeted

EASLnews@EASLnews · May 7

The networking session with @ef_clif will start soon! Head over Track Hub 4 (Cirrhosis & Complications) at 13:30! Meet @ProfPaoloAngeli, Anna Bosch, Joan Clària, Hannelie Korf, Richard Moreau, & Cristina Sánchez-Garrido! #EASLCongress

601